COVID-19 isolation strategies: What have we learned
| dc.contributor.author | Al-Tawfiq, Jaffar A. | |
| dc.contributor.author | Memish, Ziad A. | |
| dc.contributor.department | Medicine, School of Medicine | |
| dc.date.accessioned | 2023-08-09T15:00:47Z | |
| dc.date.available | 2023-08-09T15:00:47Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Since the start of the COVID-19 pandemic, infection prevention and control policies have significantly differed between different public health organization and have been complicated by the emergence of new data on Variants of Concern (VOC). Here, we try to highlight the different strategies for isolating patients with COVID-19 and point-out the evolution of such strategies over time, mainly for mildly or moderately severe SARS-CoV-2 infected patients. | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Al-Tawfiq JA, Memish ZA. COVID-19 isolation strategies: What have we learned. Travel Med Infect Dis. 2022;49:102416. doi:10.1016/j.tmaid.2022.102416 | |
| dc.identifier.uri | https://hdl.handle.net/1805/34811 | |
| dc.language.iso | en_US | |
| dc.publisher | Elsevier | |
| dc.relation.isversionof | 10.1016/j.tmaid.2022.102416 | |
| dc.relation.journal | Travel Medicine and Infectious Disease | |
| dc.rights | Publisher Policy | |
| dc.source | PMC | |
| dc.subject | COVID-19 | |
| dc.subject | Pandemics | |
| dc.subject | Public health | |
| dc.subject | SARS-CoV-2 | |
| dc.title | COVID-19 isolation strategies: What have we learned | |
| dc.type | Article | |
| ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359599/ |